Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2015

01:13 EDT 15 Apr 2015 | BioPortfolio Reports

Recently added to the BioPortfolio report store, Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2015 is a new report from Global Markets Direct published on 2015-03-10. This 22-page report is available in PDF from $1500.

Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2015


Global Markets Direct’s, ‘Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the Acumen Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Acumen Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


- The report provides brief overview of Acumen Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Acumen Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Acumen Pharmaceuticals, Inc.’s pipeline products

Reasons to buy

- Evaluate Acumen Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Acumen Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Acumen Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Acumen Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging…

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Acumen Pharmaceuticals, Inc. Snapshot 4
Acumen Pharmaceuticals, Inc. Overview 4
Key Information 4
Key Facts 4
Acumen Pharmaceuticals, Inc. - Research and Development Overview 5
Key Therapeutic Areas 5
Acumen Pharmaceuticals, Inc. - Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products - Monotherapy 8
Acumen Pharmaceuticals, Inc. - Pipeline Products Glance 9
Acumen Pharmaceuticals, Inc. - Early Stage Pipeline Products 9
Preclinical Products/Combination Treatment Modalities 9
Acumen Pharmaceuticals, Inc. - Drug Profiles 10
ACU-193 10
Product Description 10
Mechanism of Action 10
R&D Progress 10
ACU-193 Back-up 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
Drugs to Inhibit ADDL Receptor for Alzheimer's Disease 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Vaccine to Target ADDL for Alzheimer's Disease 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Acumen Pharmaceuticals, Inc. - Pipeline Analysis 15
Acumen Pharmaceuticals, Inc. - Pipeline Products by Target 15
Acumen Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 16
Acumen Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 17
Acumen Pharmaceuticals, Inc. - Recent Pipeline Updates 18
Acumen Pharmaceuticals, Inc. - Dormant Projects 19
Acumen Pharmaceuticals, Inc. - Locations And Subsidiaries 20
Head Office 20
Appendix 21
Methodology 21
Coverage 21
Secondary Research 21
Primary Research 21
Expert Panel Validation 21
Contact Us 21
Disclaimer 22

For more information open Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2015.


Original Article: Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2015


More From BioPortfolio on "Acumen Pharmaceuticals, Inc. - Product Pipeline Review - 2015"

Quick Search


Relevant Topics

Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...